Correlation Between Vitrolife and Xintela AB

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Vitrolife and Xintela AB at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Vitrolife and Xintela AB into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Vitrolife AB and Xintela AB, you can compare the effects of market volatilities on Vitrolife and Xintela AB and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Vitrolife with a short position of Xintela AB. Check out your portfolio center. Please also check ongoing floating volatility patterns of Vitrolife and Xintela AB.

Diversification Opportunities for Vitrolife and Xintela AB

0.74
  Correlation Coefficient

Poor diversification

The 3 months correlation between Vitrolife and Xintela is 0.74. Overlapping area represents the amount of risk that can be diversified away by holding Vitrolife AB and Xintela AB in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Xintela AB and Vitrolife is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Vitrolife AB are associated (or correlated) with Xintela AB. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Xintela AB has no effect on the direction of Vitrolife i.e., Vitrolife and Xintela AB go up and down completely randomly.

Pair Corralation between Vitrolife and Xintela AB

Assuming the 90 days trading horizon Vitrolife AB is expected to generate 0.55 times more return on investment than Xintela AB. However, Vitrolife AB is 1.82 times less risky than Xintela AB. It trades about -0.07 of its potential returns per unit of risk. Xintela AB is currently generating about -0.18 per unit of risk. If you would invest  25,160  in Vitrolife AB on September 3, 2024 and sell it today you would lose (2,680) from holding Vitrolife AB or give up 10.65% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthSignificant
Accuracy100.0%
ValuesDaily Returns

Vitrolife AB  vs.  Xintela AB

 Performance 
       Timeline  
Vitrolife AB 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Vitrolife AB has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest uncertain performance, the Stock's basic indicators remain stable and the newest uproar on Wall Street may also be a sign of mid-term gains for the firm private investors.
Xintela AB 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Xintela AB has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's basic indicators remain comparatively stable which may send shares a bit higher in January 2025. The newest uproar may also be a sign of mid-term up-swing for the firm private investors.

Vitrolife and Xintela AB Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Vitrolife and Xintela AB

The main advantage of trading using opposite Vitrolife and Xintela AB positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Vitrolife position performs unexpectedly, Xintela AB can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Xintela AB will offset losses from the drop in Xintela AB's long position.
The idea behind Vitrolife AB and Xintela AB pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Price Exposure Probability module to analyze equity upside and downside potential for a given time horizon across multiple markets.

Other Complementary Tools

AI Portfolio Architect
Use AI to generate optimal portfolios and find profitable investment opportunities
Efficient Frontier
Plot and analyze your portfolio and positions against risk-return landscape of the market.
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios
Sign In To Macroaxis
Sign in to explore Macroaxis' wealth optimization platform and fintech modules
Global Correlations
Find global opportunities by holding instruments from different markets